← Back to Search
Polymer-lipid Hybrid Systems: Merging The Benefits Of Polymeric And Lipid-based Nanocarriers To Improve Oral Drug Delivery
Shasha Rao, C. Prestidge
Published 2016 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
ABSTRACT Introduction: A number of biobarriers limit efficient oral drug absorption; both polymer-based and lipid-based nanocarriers have demonstrated properties and delivery mechanisms to overcome these biobarriers in preclinical settings. Moreover, in order to address the multifaceted oral drug delivery challenges, polymer-lipid hybrid systems are now being designed to merge the beneficial features of both polymeric and lipid-based nanocarriers. Areas covered: Recent advances in the development of polymer-lipid hybrids with a specific focus on their viability in oral delivery are reviewed. Three classes of polymer-lipid hybrids have been identified, i.e. lipid-core polymer-shell systems, polymer-core lipid-shell systems, and matrix-type polymer-lipid hybrids. We focus on their application to overcome the various biological barriers to oral drug absorption, as exemplified by selected preclinical studies. Expert opinion: Numerous studies have demonstrated the superiority of polymer-lipid hybrid systems to their non-hybrid counterparts in providing improved drug encapsulation, modulated drug release, and improved cellular uptake. These features have encouraged their applications in the delivery of chemotherapeutics, proteins, peptides, and vaccines. With further research expected to optimize the manufacturing and scaling up processes and in-depth pre-clinical pharmacological and toxicological assessments, these multifaceted drug delivery systems will have significant clinical impact on the oral delivery of pharmaceuticals and biopharmaceuticals.
This paper references
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.
A. Tan (2012)
Nanostructured Silica–Lipid Hybrid Microparticles: A Supersaturating Carrier for Water- and Lipid-resistant Compounds
A. Tan (2012)
Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying core
M. Homar (2009)
Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
H. Yuan (2013)
Bridging solubility between drug discovery and development.
Li Di (2012)
Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
H. Williams (2013)
Reviews the fate of polymeric nanoparticles following oral drug delivery
Physicochemical and interfacial investigation of lipid/polymer particle assemblies.
Anne-Lise Troutier (2005)
Triggered release of pharmacophores from [Ni(HAsO₃)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study.
S. Lee (2011)
M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity.
Tongtong Ma (2014)
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
O. Feeney (2014)
Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin
H. Sugihara (2012)
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
M. U. Anby (2012)
Fate of polymeric nanocarriers for oral drug delivery
L. Plapied (2011)
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
A study on the interactions of surfactants with phospholipid/polydiacetylene vesicles in aqueous solutions
Y. Su (2005)
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
Jian You (2006)
Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems.
M. Marvola (1999)
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility
D. B. Warren (2010)
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
Chapter 2.2:NANOSTRUCTURES OVERCOMING THE INTESTINAL BARRIER: DRUG DELIVERY STRATEGIES
K. Ryan (2012)
Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
S. Chakraborty (2009)
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Wean Sin Cheow (2011)
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
Doxil® – the first FDA-approved nano-drug. In: Peer D, editor. Handbook of harnessing biomaterials in nanomedicine
CB Yechezkel (2012)
Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier.
Y. Wang (2008)
Is the oral route possible for peptide and protein drug delivery?
M. Morishita (2006)
Discusses the role of lipids in the oral delivery of poorly water soluble compounds
Drug precipitation inhibitors in supersaturable formulations.
Sen Xu (2013)
Chapter 2.1:Nanostructures Overcoming the Intestinal Barrier: Physiological Considerations and Mechanistic Issues
S. Maher (2012)
Nano-carrier systems: Strategies to overcome the mucus gel barrier.
S. Dünnhaupt (2015)
Exploiting M cells for drug and vaccine delivery.
M. A. Clark (2001)
Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
A. Tan (2010)
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
S. Lee (2010)
High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes.
Ruzica Galović Rengel (2002)
Nanostructures overcoming the intestinal barrier: physiological considerations andmechanistic issues
S Maher (2012)
Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide.
A. Zvonar (2010)
PLGA-lipid liposphere as a promising platform for oral delivery of proteins.
Tongtong Ma (2014)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
M. Werle (2009)
Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance
A. Tan (2013)
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
R. Fang (2010)
Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract
K. Iwanaga (1997)
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal (2009)
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin
Aiwen Huang (2011)
Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system
B. Sarmento (2011)
Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids.
M. Garcia-Diaz (2015)
Effects of Gastrointestinal Administration of Human Insulin and a Human Insulin-Deae-Dextran Complex Entrapped in Different Compound Liposomes on Blood Glucose in Rats
A. Manosroi (1990)
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
M. Werle (2006)
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
Shasha Rao (2014)
Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods
Wean Sin Cheow (2010)
A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits.
Jian You (2005)
Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation
W. Song (2013)
In Vitro Evaluation of Polymerized Liposomes as an Oral Drug Delivery System
J. Okada (2004)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
The basics and underlying mechanisms of mucoadhesion.
J. Smart (2005)
Chapter 1:Historical View of the Design and Development of Nanocarriers for Overcoming Biological Barriers
M. Alonso (2012)
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations.
Preshita P Desai (2012)
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
K. Mohsin (2009)
Preparation of microcapsules with self-microemulsifying core by a vibrating nozzle method
M. Homar (2007)
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
A. Beloqui (2014)
Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Roger Vandecruys (2007)
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.
K. Raemdonck (2014)
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
W. Charman (2000)
High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation.
T. Nassar (2011)
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
G. Fricker (2010)
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Ping Gao (2009)
Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol
Si Shen Feng (2002)
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop (2010)
Polymerizable phospholipid analogues--new stable biomembrane and cell models.
H. Hub (1980)
An enteric-coated dry emulsion formulation for oral insulin delivery.
Eiichi Toorisaka (2005)
Chitosan-coated liposomes: characterization and interaction with leuprolide.
J. Guo (2003)
Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin
P. Fonte (2011)
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Y. Liu (2010)
Polymerized Vesicles 의 투과 특성
Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications
Dali Shukla (2011)
Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
A. Tan (2009)
Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.
H. Harde (2015)
PEGylation, successful approach to drug delivery.
F. Veronese (2005)
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
C. Pouton (2008)
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Y. Luo (2015)
Enteric Micro-Particles for Targeted Oral Drug Delivery
A. Dalmoro (2010)
Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Rokhsana Yasmin (2014)
Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin
Xiaoying Ying (2011)
Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability
Hongming Chen (1996)
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations
Ping Gao (2004)
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
X. Li (2013)
Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.
Ping Gao (2003)
Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
P. Joyce (2015)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Deepti Pandita (2015)
Handbook of Harnessing Biomaterials in Nanomedicine : Preparation, Toxicity, and Applications
D. Peer (2012)
• Demonstrates the ability of various nanostructured solid carriers to influence lipid-based drug delivery system biopharmaceutical performance
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Hongming Chen (2004)
A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles.
Caixin Guo (2009)
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Suha Attili-Qadri (2013)
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
Effects of polymer and surfactant on the dissolution and transformation profiles of cocrystals in aqueous media
Amjad Alhalaweh (2014)
Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
F. Yu (2015)
Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
D. Lee (2015)
Modulating pancreatic lipase activity with galactolipids: effects of emulsion interfacial composition.
B. Chu (2009)
The study of the emulsification efficiency of Aerosil and HPMCAS type and their ratio to stabilize emulsions of zedoary turmeric oil
Jian You (2006)
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
Christel A S Bergström (2014)
M cells in Peyer's patches of the intestine.
A. Gebert (1996)
Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Vinay Kumar Venishetty (2012)
Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy.
S. Lee (2010)
Role of Particle Size in Phagocytosis of Polymeric Microspheres
J. Champion (2008)
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
H. Takeuchi (2005)
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.
Carolina Salvador-Morales (2009)
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen
A. Tan (2013)
Polymer-caged lipsomes: a pH-responsive delivery system with high stability.
S. Lee (2007)
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
S. Jain (2012)
Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
F. Wan (2008)
Targeting polymerised liposome vaccine carriers to intestinal M cells.
M. A. Clark (2001)
Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems
Tahnee J. Dening (2015)
Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
S. Jain (2012)
Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Shasha Rao (2014)
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Shasha Rao (2015)
Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Héctor R Guzmán (2007)
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.
H. Williams (2014)
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats☆
K. Gradauer (2013)
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Laura M Ensign (2012)
PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide Delivery
P. Zou (2013)
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
F. Hu (2005)
The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers
A. Clausen (2004)
This paper is referenced by
An update on polymer-lipid hybrid systems for improving oral drug delivery
Sajedehsadat Maghrebi (2019)
Inhalable hybrid nanocarriers for respiratory disorders
P. Maurya (2020)
Emergence of Polymer-Lipid Hybrid Systems in Healthcare Scenario
Anamika Jain (2018)
Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles
Hala Mahmoud Helal (2016)
Polymer and Lipid-based Nanomedicine of Synergistic Drug Combination for Improving Chemotherapy of Multidrug Resistant Breast Cancer
Rui Xue Zhang (2016)
Hybrid Vesicular Drug Delivery Systems for Cancer Therapeutics
M. Mohammadi (2018)
Advances of Nano-Structured Extended-Release Local Anesthetics
Yumiao He (2020)
Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes
Elisabet Martí Coma-Cros (2018)
Lipid and PLGA hybrid microparticles as carriers for protein delivery
Chengyu Wu (2018)
Lipid Nanocarriers: Promising Approach for Oral Drug Delivery System
V. Yadav (2020)
Recent Advances in Hybrid Biomimetic Polymer-Based Films: from Assembly to Applications
Agata Krywko-Cendrowska (2020)
Murine models for mucosal tolerance in allergy.
U. Smole (2017)
Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform
R. Ganugula (2017)
Optimization of formulation processes using Design Expert® Software for preparation of polymeric blends-artesunate-amodiaquine HCl microparticles
J. D. Ogbonna (2017)
In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Chengyu Wu (2019)
Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer‐lipid hybrid nanoparticles
Tianyang Ren (2018)
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
Parisa Ghasemiyeh (2018)
How can nanoparticles contribute to antituberculosis therapy?
J. Costa-Gouveia (2017)
Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice
Xiaoyan Bao (2020)
Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Jingxin Gou (2017)
Tamoxifen-loaded PLA/DPPE-PEG lipid-polymeric nanocapsules for inhibiting the growth of estrogen-positive human breast cancer cells through cell cycle arrest
Niloofar Behdarvand (2020)
Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin.
Bin Xu (2017)
Lipid polymer hybrid carrier systems for cancer targeting: A review
Z. Chaudhary (2018)
Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Kuldeep Rajpoot (2020)
Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
R. Zhang (2017)
Freeze-dried eudragit-hyaluronan multicompartment liposomes to improve the intestinal bioavailability of curcumin.
Ana Catalan-Latorre (2016)
Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
J. Han (2018)
Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats
E. Abdou (2019)
Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
Ying Liu (2017)
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman (2020)